Biotechnology

Lexaria Begins New Nicotine Formulation Creation and Evaluation Program

April 11, 2022 9:00 AM

KELOWNA, BC / ACCESSWIRE / April 11, 2022 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces it has entered new agreements with Altria Client Services, LLC ("Altria"). Under the terms of these agreements, Lexaria will receive a fee to provide certain DehydraTECH powder-based nicotine formulations to be evaluated by Altria. The new agreements are in effect...

Read more

enVVeno Medical Announces New U.S. VenoValve(R) Patent

April 11, 2022 8:05 AM

- Expanding patent portfolio bolsters protection of the Company's lead product -The VenoValve is a potential first-in-class treatment for patients suffering from Chronic Venous Insufficiency (CVI) of the deep veins of the leg - There are currently no effective treatments for patients with deep venous CVI - The VenoValve is currently being evaluated in leading hospitals throughout the U.S. in the ongoing SAVVE U.S pivotal trial IRVINE, CA /...

Read more

Enzolytics IPF Immune(TM) Introduced to Large and Small Retail Buyers at Recent ECRM "Weight Management, Nutrition, and Vitamin Program"

April 11, 2022 7:00 AM

COLLEGE STATION, TX / ACCESSWIRE / April 11, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/). Large and small retail buyers were introduced to Enzolytics IPF Immune™, an immune modulator that debuted at ECRM's "Weight Management, Nutrition, and Vitamin Program." "ECRM offered the Company the unique opportunity to present its new product to large and small retailers," said Charles S. Cotropia, CEO of Enzolytics, Inc. "The retail...

Read more

All GVB Biopharma Products Clear New, Stricter Food Safety Standards in UK

April 7, 2022 4:40 PM

LONDON, UK / ACCESSWIRE / April 7, 2022 / GVB Biopharma, a biopharmaceutical company specializing in hemp and cannabis-related white-label consumer products, announced today that all of its products remain approved by the Food Standards Agency (FSA) after the organization created stricter market standards for foods containing cannabidiol (CBD) sold in most United Kingdom (UK) countries. On April 1, 2022, the FSA, a UK government public health...

Read more

Helix Announces Board Resignation

April 7, 2022 12:30 PM

RICHMOND HILL, ON / ACCESSWIRE / April 7, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological platform DOS47, today announced the resignation of Dr. Krzysztof Saczek from the Board of Directors with immediate effect. "On behalf of Helix, I would like to thank Krzysztof for his service to...

Read more

BioInvent International AB publishes Annual Report 2021

April 7, 2022 10:00 AM

LUND, SE / ACCESSWIRE / April 7, 2022 / BioInvent International (STO:BINV) BioInvent International AB (publ) (Nasdaq Stockholm: BINV) today announced that the Annual Report for 2021 has been published. The Annual Report is attached to this press release in pdf format and is available on the company's website, www.bioinvent.com. About BioInvent BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers...

Read more

CB Scientific, Inc. Announces Uplist to the OTCQB(R) Venture Market

April 6, 2022 10:30 AM

Shareholders to benefit from greater transparency and improved liquidity ESCONDIDO, CA / ACCESSWIRE / April 6, 2022 / CB Scientific. Inc. (OTCQB:CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products and services, today announces its successful uplisting from the OTC Pink Sheets to the OTCQB® Venture Market (the "OTCQB"). The Company will commence trading on the OTCQB...

Read more

Bakhu Holdings Selects Mitchell ("Mitch") Kahn for Key Consulting Services

April 6, 2022 9:09 AM

LONG BEACH, CA / ACCESSWIRE / April 6, 2022 / Bakhu Holdings, Corp. (OTC PINK:BKUH) today announced an agreement to retain Mitchell ("Mitch") Kahn, 61, founder and former CEO of Grassroots Cannabis, as a consultant to assist with marketing and financing activities in furtherance of the Company's long-term objectives to grow and optimize the value of the Company. "The Board selected Mitch out of many fine candidates based on his preliminary input...

Read more

Pressure BioSciences Leveraging Strong FY2021 Operational and Financial Successes, Worldwide Customer Base, Substantial IP Estate, and Three Powerful Technology Platforms to Accelerate Strategic Company Transformation in 2022

April 5, 2022 11:25 AM

Q4 and FY2021 Total Revenue Increased 91% and 64% Respectfully Over Same Periods in 2020; PCT, BaroFold, and PBI Agrochem Groups Scored Important Gains in 2021; UST Platform Achieved Critical 2021 Goals - Discussions Ongoing with Key Leaders in Multiple Markets Investor Conference Call Scheduled for Tuesday April 5 at 4:30 PM ET SOUTH EASTON, MA / ACCESSWIRE / April 5, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a...

Read more

Genomics England Expands Nanopore Use in Cancer

April 4, 2022 9:10 AM

Genomics England expands use of Oxford Nanopore sequencing in cancer Oxford Nanopore technology will be used by Genomics England to investigate and validate at increasing scale the benefits of sequencing for improving patient care and advancing research to develop new treatments. Genomics England's "Long-Read Sequencing Programme" takes advantage of Oxford Nanopore's ability to sequence any-length fragments of DNA, including long and ultra-long...

Read more

Aqualung Therapeutic's ALT-100 Monoclonal Antibody Cited as A Novel Therapeutic for Lung Fibrosis

April 4, 2022 8:36 AM

TUCSON, AZ / ACCESSWIRE / April 4, 2022 / Aqualung Therapeutics, an early-stage immunotherapeutics biotech company developing an anti-inflammatory therapeutic platform for unchecked inflammation has published another study touting the effectiveness of its anti-inflammatory ALT-100 monoclonal antibody (mAb). A study reported in the March issue of the American Journal of Respiratory and Cell Molecular Biology (AJRCMB) (Alexander N. Garcia MD, PhD...

Read more

Apollo Endosurgery Appoints Jeannette Bankes to Board of Directors

April 4, 2022 7:15 AM

Veteran Brings 30 Years of Multinational Healthcare Leadership Experience AUSTIN, TX / ACCESSWIRE / April 4, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced the appointment of Jeannette Bankes to its Board of Directors, bringing the number of board members to eight. Bankes is the President and General Manager of the...

Read more

Thermic Science Reports Investment Package For Cannabis Science Acquisition, Thermic Tech Takes Off With Successful American States University “Make That Change” Campaign Launch

April 1, 2022 10:50 AM

NASHVILLE, TN / ACCESSWIRE / April 1, 2022 / Thermic Science International Corporation, (OTC:ENDO), a U.S. an Advanced technology Global Consortium providing individuals and Companies with a framework to cooperate and collaborate with other individuals, peers, and stakeholders worldwide, take it to the Digital Divide and provide equal access to all through its American States University Digital HUB. Thermic Science has completed the 1st wave of...

Read more

Materna Medical Activates All US EASE Prep Pivotal Clinical Trial Sites

March 31, 2022 8:00 AM

Top study leadership overseeing novel device related clinical research in OBGYN MOUNTAIN VIEW, CA / ACCESSWIRE / March 31, 2022 / Materna Medical, an OBGYN platform company dedicated to protecting women's pelvic health, announced the completion of the activation of the fifteenth U.S. clinical study site participating in the pivotal EASE trial. This clinical study is evaluating the safety and effectiveness of the Prep device and will investigate...

Read more

ONT Shows New High-Accuracy, High-Output Chemistry

March 30, 2022 9:20 AM

Oxford Nanopore technology update: CTO Clive G Brown unveils latest sequencing chemistry with highest performance to date, Short Fragment Mode and latest methylation performance evaluations Clive G Brown, CTO, Oxford Nanopore Technologies, reviews some of the latest technology updates during a webinar today. Highlights include performance and base modification calling improvements, as well as updates on the recently-released Short Fragment Mode...

Read more

International Stem Cell Corporation Announces 2021 Fourth Quarter and Year-End Results

March 30, 2022 9:15 AM

SAN DIEGO, CA / ACCESSWIRE / March 30, 2022 / International Stem Cell Corporation (OTCQX:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update and announced fourth quarter and year-end financial results for the period ending on December 31, 2021. "We are pleased with the outcome...

Read more

Dr AnnaRx Announces Rob Simbowe CBD Muscle and Joint Rubs

March 30, 2022 8:40 AM

CAPE TOWN, SA / ACCESSWIRE / March 30, 2022 / WUHAN GENERAL GROUP, INC. (WUHN) ("WGG'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research is pleased to share the following update: Dr. AnnaRx™ is pleased to announce the launch of its new line of CBD Muscle and Joint Rubs endorsed and promoted by MMA Pro Fighter Rob "The Black Tiger" Simbowe. The initial line will consist...

Read more

Edesa Biotech Appoints Strategy Expert to Board of Directors

March 29, 2022 9:00 AM

TORONTO, ON / ACCESSWIRE / March 29, 2022 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced the appointment of Jennifer M. Chao to the company's Board of Directors. "Ms. Chao's appointment to our Board comes at an exciting time as we prepare for the most meaningful milestones yet in our clinical programs. Her extensive experience in the life...

Read more

DrazCanna, Inc. (OTCBB: SIBED) - A New, US Based, Public Cannabis Company paves its way into the Marijuana Bio-Pharmaceutical Research and Development Supply Chain

March 28, 2022 9:00 AM

"Sometimes timing is everything for an entrepreneur". US Senate unanimously approves Marijuana Reform Bill on the same day that the House schedules cannabis legalization vote…and it's your first day as a U.S. public company in the cannabis industry; the realization of a 6+ year entrepreneurial journey. DEARBORN HEIGHTS, MI / ACCESSWIRE / March 28, 2022 / "The timing is unbelievable" exclaimed Hussein Anani, President of DrazCanna, Inc. For the...

Read more

Qrons Announces Effectiveness of Its Post-Effective Amendment to Its Registration Statement

March 28, 2022 8:45 AM

NEW YORK, NY / ACCESSWIRE / March 28, 2022 / Qrons Inc. (OTCQB:QRON), an innovative biotechnology company dedicated to developing next generation treatments for unmet neuronal diseases, using tissue engineering, stem cells and machine learning synergic technologies announced that the SEC declared effective its filing on March 18, 2022 of its Post- Effective Amendment to its Registration Statement filed on Form S-1 with the U.S. Securities and...

Read more